ArticleThe Journal of biological chemistry2026
A tri-specific EGFR/cMet/VEGF antibody demonstrates potent multi-mechanistic activity in preclinical triple-negative breast cancer models.
Pu Pu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.